- Ownership
- Activity
KERX Stock Ownership Activity
KERYX BIOPHARMACEUTICALS 13F holders
No value investing guru has made any change to the KERYX BIOPHARMACEUTICALS (KERX) position according to the gurus' latest SEC quarterly report(s).
Which gurus or hedge funds are buying KERX now?
According to the latest SEC filing(s) KERYX BIOPHARMACEUTICALS (KERX) has not been purchased by any super investor.
To see more about who is investing in KERYX BIOPHARMACEUTICALS (KERX), please go to the KERX ownership page.
2018 Q4
(2 results)
AVG reported price*: $3.40
2018 Q3
(1 result)
Reported price*: $3.40
2018 Q2
(1 result)
Reported price*: $3.76
2017 Q4
(1 result)
Reported price*: $4.65
2016 Q1
(1 result)
Reported price*: $4.67
2015 Q4
(1 result)
Reported price*: $5.05
2015 Q3
(1 result)
Reported price*: $3.52
2015 Q2
(1 result)
Reported price*: $9.98
2015 Q1
(1 result)
Reported price*: $12.73
2014 Q3
(1 result)
Reported price*: $13.75
2014 Q2
(1 result)
Reported price*: $15.38
2014 Q1
(1 result)
Reported price*: $17.04
13 of 13
Shares, change to shares, sold shares - split-adjusted.
Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.
Value or Price - If the security is completely sold out, we show the reported value (or price) prior to the actual period.